Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer

British Journal of Cancer

Volumn 79, Issue 2, 1999, Pages 354-359

  Tokunaga, T ^a   Nakamura, M ^a   Oshika, Y ^a   Abe, Y ^a   Ozeki, Y ^b   Fukushima, Y ^a   Hatanaka, H ^a   Sadahiro, S ^a   Kijima, H ^a   Tsuchida, T ^a   Yamazaki, H ^a   Tamaoki, N ^a   Ueyama, Y ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Colon cancer; Thrombospondin; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; CD34 ANTIGEN; THROMBOSPONDIN; THROMBOSPONDIN 1; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER STAGING; COLON CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION;

EID: 0032894743     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690056     Document Type: Article

References (45)

1. Baenziger NL, Brodie GN and Majerus PW (1972) Isolation and properties of a thrombin sensitive protein of human platelets. J Biol Chem 247: 2723-2731
2. Bertin N, Clezardin P, Kubiak R and Frappart L (1971) Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Cancer Res 57: 396-399
3. Bornstein P (1992) Thrombospondins: structure and regulation of expression. FASEB J 6: 3290-3299
4. Bornstein P, O'Rourke K, Wikstrom K, Wolf FW, Katz R, Li P and Dixit VM (1991) A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J Biol Chem 266: 12821-12824
5. Clezardin P, Frappart L, Clerget M, Pechoux C and Delmas PD (1993) Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Cancer Res 53: 1421-1430
6. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM and Feder J (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84: 1470-1478
7. Gehron RP, Young MF, Fisher LW and McClain TD (1989) Thrombospondin is an osteoblast-derived component of mineralized extracellular matrix. J Cell Biol 108: 719-727
8. Graham C, Rivers J, Kerbel R, Stankiewicz K and White W (1994) Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. Am J Pathol 145: 510-514
9. Grossfeld GD, Shi SR, Ginsberg DA, Rich KA, Skinner DG, Taylor CR and Cote RJ (1996) Immunohistochemical detection of thrombospondin-1 in formalin-fixed, paraffin-embedded tissue. J Histochem Cytochem 44: 761-766
10. Grossfeld GD, Ginsberg DA, Stein JP, Bochner BH, Esrig D, Groshen S, Dunn M, Nichols PW, Taylor CR, Skinner DG and Cote RJ (1997) Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89: 219-227
11. Hsu SC, Volpert OV, Steck PA, Mikkelsen T, Poverini PJ, Rao S, Chou P and Bouck N (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cacer Res 56: 5684-5691
12. Iruela-Arispe ML, Bornstein P and Sage H (1991) Thrombospondin exerts an anti-angiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88: 5026-5030
13. Jaffe EA, Ruggiero JT, Leung LLK, Doyle MJ, McKeon-Longo PJ and Mosher DF (1983) Cultured human fibloblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sci USA 80: 998-1002
14. Jaffe EA, Ruggiero JT and Falcon DJ (1985) Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65: 79-84
15. Labell TL and Byers PH (1993) Sequence and characterization of the complete human thrombospondin-2 cDNA: potential regulatory role for the 3′ untranslated region. Genomics 17: 225-229
16. Laherty CD, O'Rourke K, Wolf FW, Katz R, Seldin MF and Dixit VM (1992) Characterization of mouse thrombospondin 2 sequence and expression during cell growth and development. J Biol Chem 267: 3274-3281
17. Laiho M, Ronnstrand L, Heino J, Decaprio JA, Ludlow JW, Livingston DM and Massague J (1991) Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40T antigen-sensitive growth-sensitive growth-inhibitory events. Mol Cell Biol 11: 972-978
18. Lawler J (1986) The structural and functional properties of thrombospondin. Blood 67: 112-123
19. Lawler J, Duquette M, Whittaker CA, Adams JC, McHenry K and Desimone DW (1993) Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol 120: 1059-1067
20. Legrand C, Thibert V, Dubernard V, Begault B and Lawler J (1992) Molecular requirements for the interaction of thrombospondin with thrombin-activated human platelets: modulation of platelet aggregation. Blood 79: 1995-2003
21. Macchiarini P, Fontanini G, Hardin MJ, Squartini F and Angeletti CA (1992) Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340: 145-146
22. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, Onoda N, Kato Y, Nitta A, Arimoto Y, Kondo M and Sawa M (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 13: 477-181
23. Majack RA, Mildbrandt J and Dixit VM (1987) Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J Biol Chem 262: 8821-8825
24. Oldberg A, Antonsson P, Lindblom K and Heinegard D (1992) COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 267: 22346-22350
25. O'Shea KS and Dixit VM (1988) Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo. J Cell Biol 107: 2737-2748
26. O'Shea KS, Liu LHJ, Kinnunen LH and Dixit VM (1990) Role of the extracellular matrix protein thrombospondin in the early development of the mouse embryo. J Cell Biol 111: 2713-2723
27. Panetti TS, Chen H, Misenheimer TM, Getzler SB and Mosher DF (1997) Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2. J Lab Clin Med 129: 208-216
28. Qian X and Tuszynski GP (1996) Expression of thrombospondin-1 in cancer: a role in tumor progression. Proc Soc Exp Biol Med 212: 199-207
29. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasaws S, Sasazuki T and Kerbel RS (1995) Mutant ras oncogenes upregulate VEGF/PF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55: 4575-4580
30. Roberts DD, Sherwood JA and Ginsburg V (1987) Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol 104: 131-139
31. Sage EH and Bornstein P (1991) Extracellular proteins that modulate cell-matrix interactions. J Biol Chem 266: 14831-14834
32. Stellmach V, Volpert OV, Crawford SE, Lawler J, Hynes RO and Bouck N (1996) Tumour suppresser genes and angiogenesis. Eur J Cancer 32A: 2304-2400
33. Takahashi Y, Kitadai Y, Bucana CD, Cleary RK and Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55: 3964-3968
34. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR and Ellis LM (1997) Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132: 541-546
35. Taraboletti G, Roberts DD and Liotta LA (1987) Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol 105: 2409-2415
36. Tokunaga T, Oshika Y, Abe Y, Ozeki Y, Sadahiro S, Kijima H, Tsuchida T, Yamazaki H, Ueyama Y, Tamaoki N and Nakamura M (1998) Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br J Cancer 77: 996-1002
37. Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF and Bouck N (1995) Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217: 326-332
38. Volpert OV, Dameron KM and Bouck N (1997) Sequential development of an angiogenic phenotype by human fibloblasts progressing to tumorgenicity. Oncogene 14: 1495-1502
39. Vos HL, Devarayalu S, De Vries Y and Bornstein P (1992) Thrombospondin 3 (Thbs3), a new member of the thrombospondin family. J Biol Chem 267: 12192-12196
40. Warren SR, Yuan H, Matli RM, Gillett AN and Ferrara N (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorgenesis in a mouse model of experimental liver metastasis. J Clin Invest 95: 1789-1797
41. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8
42. Weidner N, Carro PR, Flax J, Blumenfeld W and Folkman J (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143: 401-409
43. Weinstat-Saalow DL, Zabrenetzky VS, Vanhoutte K, Frazier WA, Roberts DD and Steeg PS (1994) Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54: 6504-6511
44. Wight TN, Raugi GJ, Mumby SM and Bornstein P (1985) Light microscopic immunolocation of thrombospondin in human tissues. J Histochem Cytochem 33: 295
45. Zabrenetzky V, Harris CC, Steeg PS and Roberts DD (1994) Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung, and breast carcinoma cell lines. Int J Cancer 59: 191-195